Monoarticular septic arthritis in a patient with juvenile rheumatoid arthritis under etanercept treatment.
A 7-year-old girl with polyarticular type juvenile rheumatoid arthritis (JRA) presented with acute onset of right hip pain with limited range of motion and fever within the past two days. She had received etanercept for more than one year. Percutaneous arthrocentesis was performed and showed a white blood cell count of 84150/μL in the synovial fluid, although the culture showed negative results. The fever and right hip pain completely resolved after antibiotic treatment. Herein, we report the first case of septic monoarthritis of JRA under etanercept treatment.
Lin
Kai-Cheng
KC
Department of Family Medicine, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Kaohsiung, Taiwan.
Liang
Chi-Di
CD
Yang
Kuender D
KD
Yu
Hong-Ren
HR
Kuo
Ho-Chang
HC
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects*; D018771:Arthralgia / Q000139:chemically induced / Q000503:physiopathology; D001170:Arthritis, Infectious / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D001171:Arthritis, Juvenile / Q000188:drug therapy*; D001696:Biomechanical Phenomena; D002648:Child; D000068800:Etanercept; D005260:Female; D005334:Fever / Q000139:chemically induced; D006621:Hip Joint / Q000000981:diagnostic imaging / Q000503:physiopathology*; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D010147:Pain Measurement; D011237:Predictive Value of Tests; D011877:Radionuclide Imaging; D016059:Range of Motion, Articular; D018124:Receptors, Tumor Necrosis Factor; D013997:Time Factors; D016896:Treatment Outcome; D051598:Whole Body Imaging
D000900:Anti-Bacterial Agents; D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept